Skip to main content
2026 CRT Conference Main banner

CRT 2026

Disparities in Interventional Cardiology

Session:: Disparities in Interventional Cardiology

Panel Discussion | Disparities in Interventional Cardiology | Imaging, PAD and Structural Heart

Saturday, March 7, 2026
10:03 AM - 10:23 AM EST
Location: Cabinet

    Moderator(s)

  • Joaquin E. Cigarroa, MD

    Director, Knight Cardiovascular Institute
    OHSU Knight Cardiovascular Institute
    Portland, Oregon, United States

    Disclosure information not submitted.

  • Michele D. Voeltz, MD, FACC, FSCAI

    Attending Physician
    Northside Cardiovascular Institute
    Buford, Georgia, United States

    Disclosure information not submitted.

  • Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC

    Chair, Department of Medicine
    University of Louisville
    Louisville, Kentucky, United States

    Disclosure(s): No financial relationships to disclose

    • Panel Discussant(s)

  • JC

    Jennifer L. Carter, DPT

    Senior Physical Therapist
    Medstar Washington Hospital Center
    Silver Spring, Maryland, United States

    Disclosure(s): No financial relationships to disclose

  • Sara D. Collins, MD

    Medical Director
    Flourish Research Bowie
    Bowie, Maryland, United States

    Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Eli Lilly & Company: Consulting Fees (e.g., advisory boards) (Ongoing); Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Foluso A. Fakorede, MD

    CEO
    Cardiovascular Solutions Of Central Mississippi-Fusion Vascular
    Grenada , Mississippi, United States

    Disclosure(s): No financial relationships to disclose

  • Aaron Horne, Jr., MD, MBA

    Structural Interventionalist
    Summit Health
    Berkeley Heights, New Jersey, United States

    Disclosure information not submitted.

  • Morton J. Kern, MD, MSCAI, FACC, FAHA

    Interventional Cardiologist
    VA Long Beach Health Care System
    Long Beach, California, United States

    Disclosure(s): Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Ramesh Mazhari, MD, MBA

    Professor of Medicine, Director of Cardiovascular ICU
    George Washington University, District of Columbia, United States

    Disclosure(s): No financial relationships to disclose

  • Craig M. Walker, MD

    Chief Medical Director/President/Founder
    Cardiovascular Institute of the South
    Gray, Louisiana, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Kim Allan Williams, MD, MACC, FAHA, MASNC, FESC, Sr.: No financial relationships to disclose
Jennifer L. Carter, DPT: No financial relationships to disclose
Sara D. Collins, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Eli Lilly & Company: Consulting Fees (e.g., advisory boards) (Ongoing); Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing)
Foluso A. Fakorede, MD: No financial relationships to disclose
Morton J. Kern, MD, MSCAI, FACC, FAHA: Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Ramesh Mazhari, MD, MBA: No financial relationships to disclose
Craig M. Walker, MD: No financial relationships to disclose